These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 37156676

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
    Zhao YJ, Chen WX, Wu DS, Zhang WY, Zheng LR.
    Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
    [Abstract] [Full Text] [Related]

  • 43. Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis.
    Iavarone M, Piscaglia F, Vavassori S, Galassi M, Sangiovanni A, Venerandi L, Forzenigo LV, Golfieri R, Bolondi L, Colombo M.
    J Hepatol; 2013 Jun; 58(6):1188-93. PubMed ID: 23485522
    [Abstract] [Full Text] [Related]

  • 44. Interobserver Agreement for Contrast-Enhanced Ultrasound (CEUS)-Based Standardized Algorithms for the Diagnosis of Hepatocellular Carcinoma in High-Risk Patients.
    Schellhaas B, Pfeifer L, Kielisch C, Goertz RS, Neurath MF, Strobel D.
    Ultraschall Med; 2018 Dec; 39(6):667-674. PubMed ID: 29879746
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound-based multivariable model analysis.
    Duan Y, Xie X, Li Q, Mercaldo N, Samir AE, Kuang M, Lin M.
    Eur Radiol; 2020 Sep; 30(9):4741-4751. PubMed ID: 32307563
    [Abstract] [Full Text] [Related]

  • 47. VueBox® perfusion analysis of dynamic contrast enhanced ultrasound provides added value in the diagnosis of small thyroid nodules.
    Huang Y, Wang Y, Liu L, Zhu L, Qiu Y, Zuo D, Lu X, Dong Y, Jung EM, Wang W.
    Clin Hemorheol Microcirc; 2023 Sep; 83(4):409-420. PubMed ID: 36683500
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Dynamic enhancement patterns of intrahepatic cholangiocarcinoma in cirrhosis on contrast-enhanced computed tomography: risk of misdiagnosis as hepatocellular carcinoma.
    Li R, Cai P, Ma KS, Ding SY, Guo DY, Yan XC.
    Sci Rep; 2016 May 26; 6():26772. PubMed ID: 27226026
    [Abstract] [Full Text] [Related]

  • 51. Contrast enhanced ultrasound in mixed hepatocellular cholangiocarcinoma: Case series and review of the literature.
    Dong Y, Teufel A, Trojan J, Berzigotti A, Cui XW, Dietrich CF.
    Dig Liver Dis; 2018 Apr 26; 50(4):401-407. PubMed ID: 29233685
    [Abstract] [Full Text] [Related]

  • 52. Differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma based on spatial and channel attention mechanisms.
    Huang JL, Sun Y, Wu ZH, Zhu HJ, Xia GJ, Zhu XS, Wu JH, Zhang KH.
    J Cancer Res Clin Oncol; 2023 Sep 26; 149(12):10161-10168. PubMed ID: 37268850
    [Abstract] [Full Text] [Related]

  • 53. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B, Görtz RS, Pfeifer L, Kielisch C, Neurath MF, Strobel D.
    Eur J Gastroenterol Hepatol; 2017 Sep 26; 29(9):1036-1044. PubMed ID: 28562394
    [Abstract] [Full Text] [Related]

  • 54. Dynamic enhancement pattern of intrahepatic cholangiocarcinoma on contrast-enhanced ultrasound: the correlation with cirrhosis and tumor size.
    Lu Q, Xue LY, Wang WP, Huang BJ, Li CX.
    Abdom Imaging; 2015 Aug 26; 40(6):1558-66. PubMed ID: 25725793
    [Abstract] [Full Text] [Related]

  • 55. Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging.
    Huang B, Wu L, Lu XY, Xu F, Liu CF, Shen WF, Jia NY, Cheng HY, Yang YF, Shen F.
    Radiology; 2016 Oct 26; 281(1):150-7. PubMed ID: 27077381
    [Abstract] [Full Text] [Related]

  • 56. Imaging features of combined hepatocellular-cholangiocarcinoma on contrast-enhanced ultrasound: correlation with clinicopathological findings.
    Ye J, Xie X, Lin Y, Liu B, Wang W, Huang X, Huang G.
    Clin Radiol; 2018 Mar 26; 73(3):237-243. PubMed ID: 29122222
    [Abstract] [Full Text] [Related]

  • 57. Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.
    Strobel D, Jung EM, Ziesch M, Praktiknjo M, Link A, Dietrich CF, Klinger C, Schultheiß M, Jesper D, Schellhaas B.
    Eur Radiol; 2021 Oct 26; 31(10):7614-7625. PubMed ID: 33855588
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Ichikawa S, Isoda H, Shimizu T, Tamada D, Taura K, Togashi K, Onishi H, Motosugi U.
    Eur Radiol; 2020 Nov 26; 30(11):5992-6002. PubMed ID: 32500195
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.